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Introduction
The process of cell migration is pivotal to many fundamental 
physiological processes, including embryonic and fetal develop­
ment, immune responses, wound healing, and tissue homeostasis. 
Consequently, altered function of components of the migratory 
machinery is associated with severe pathophysiological con­
ditions, including developmental defects, chronic inflammatory 
diseases, and cancer metastasis (Ridley et al., 2003; Vicente­
Manzanares et al., 2005; Schwab et al., 2007).
Cell migration is a complex multistep process involving 
extensive cytoskeletal rearrangement and the concerted action of 
multiple ion transport proteins and membrane receptors. These 
processes result in the formation of lamellipodia and other   
protrusive structures and in local changes of cell–matrix inter­
actions and cell volume, which collectively enable the cell to 
move forward (Ridley et al., 2003; Vicente­Manzanares et al., 
2005; Schwab et al., 2007). Directional migration relies on the 
ability of the cell to sense and react to chemosensory stimuli (Wu, 
2005) such as PDGF (Heldin and Westermark, 1999; Jechlinger 
et al., 2006). Notably, exposure to PDGF activates the ubiquitous 
plasma membrane Na
+/H
+ exchanger NHE1 (Cassel et al., 1983; 
Ma et al., 1994; Yan et al., 2001), which is a central player in the 
regulation of proliferation, survival, and migration (Putney et al., 
2002; Pedersen, 2006; Stock and Schwab, 2006). We and others 
have demonstrated an essential role for NHE1 in cell migration 
and invasion in many cell types, including a variety of cancer 
cell types (Lagana et al., 2000; Denker and Barber, 2002; Stock 
W
e  previously  demonstrated  that  the  primary   
cilium  coordinates  platelet-derived  growth 
factor (PDGF) receptor (PDGFR) –mediated 
migration in growth-arrested fibroblasts. In this study, we 
investigate  the  functional  relationship  between  ciliary 
PDGFR- and the Na
+/H
+ exchanger NHE1 in directional 
cell migration. NHE1 messenger RNA and protein levels are 
up-regulated in NIH3T3 cells and mouse embryonic fibro-
blasts (MEFs) during growth arrest, which is concomitant 
with cilium formation. NHE1 up-regulation is unaffected 
in Tg737
orpk MEFs, which have no or very short primary 
cilia. In growth-arrested NIH3T3 cells, NHE1 is activated by 
the specific PDGFR- ligand PDGF-AA. In wound-healing   
assays  on  growth-arrested  NIH3T3  cells  and  wild-type 
MEFs, NHE1 inhibition by 5-(N-ethyl-N-isopropyl) amilo-
ride  potently  reduces  PDGF-AA–mediated  directional   
migration. These effects are strongly attenuated in inter-
phase NIH3T3 cells, which are devoid of primary cilia, and 
in Tg737
orpk MEFs. PDGF-AA failed to stimulate migration 
in NHE1-null fibroblasts. In conclusion, stimulation of direc-
tional migration in response to ciliary PDGFR- signals is 
specifically  dependent  on  NHE1  activity,  indicating  that 
NHE1 activation is a critical event in the physiological 
response to PDGFR- stimulation.
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migration  in  growth­arrested  Tg737
orpk  mutant  MEFs  is  un­
affected by either PDGF­AA or EIPA. Furthermore, PDGF­AA 
fails to stimulate migration in NHE1­deficient fibroblasts. We 
conclude that in fibroblasts, PDGFR­ signaling initiated in 
the primary cilium controls directional migration responses via 
up­regulation of NHE1 activity, indicating that NHE1 activa­
tion is a critical event in the physiological response to activa­
tion of PDGFR­.
Results
Expression and localization of NHE1  
in NIH3T3 fibroblasts and in WT and 
Tg737
orpk MEFs
We first asked whether NHE1 is up­regulated during growth   
arrest in NIH3T3 fibroblasts (i.e., concomitant with formation of 
the primary cilium). NIH3T3 cells were serum starved for 0, 12, 
and 48 h, and mRNA and protein levels were measured by quan­
titative PCR using specific NHE1 TaqMan probes and Western 
blotting, respectively. As shown in Fig. 1 A (top), the NHE1 
mRNA level was up­regulated about twofold after both 12 and 
48 h of serum starvation. The protein level increased more slowly 
and was nearly tripled after 48 h of serum starvation (Fig. 1 A, 
bottom). NHE1 up­regulation was reversible upon reentry into 
the cell cycle (Fig. 1 A).
To test whether NHE1 up­regulation during growth arrest 
depends on the formation of the primary cilium, we performed 
similar experiments in WT MEFs, which, as previously re­
ported, grow cilia at quiescence, and in Tg737
orpk mutant MEFs, 
which form no or only very short primary cilia (Fig. 1 B, a and b; 
Schneider et al., 2005). Similar to the findings in NIH3T3 cells, 
the NHE1 protein level was nearly tripled at time 48 h after   
serum starvation in both WT and Tg737
orpk MEFs (Fig. 1 C). 
Collectively, these data indicate that NHE1 is a gas protein but that, 
in contrast to the up­regulation of PDGFR­ during growth ar­
rest (Schneider et al., 2005), up­regulation of NHE1 is indepen­
dent of assembly of the primary cilium. In growth­arrested WT 
and Tg737
orpk MEFs, NHE1 localized to the plasma membrane, 
in particular to lamellipodia­like structures at the edges of the 
cells and intracellularly, in perinuclear membranes and in a cyto­
plasmic vesicular­like pattern (Fig. 1 B, c and d). A similar pattern 
of localization was observed in NIH3T3 cells (unpublished data). 
The NHE1 localization pattern was not detectably different in WT 
or Tg737
orpk MEFs after 1 h of exposure to 50 ng/ml PDGF­AA 
(n = 3; unpublished data). Collectively, these results demon­
strate that NHE1 expression is up­regulated concomitant with 
formation of the primary cilium and that neither expression nor 
localization of NHE1 are compromised in Tg737
orpk MEFs.
NHE1 activity in NIH3T3 cells
Because NHE1 activity is very tightly regulated (Pedersen, 
2006), an up­regulation of NHE1 expression does not mean that 
NHE1 activity is also up­regulated. To address this point, NHE1 
activity was determined in NIH3T3 fibroblasts using an NH4Cl 
prepulse, which is a classical protocol for evaluating intracellu­
lar pH (pHi) recovery after an acid load (Boron, 2004). In this 
protocol, the cells initially rapidly alkalinize as NH3 diffuses 
et al., 2005, 2007; Cardone et al., 2005b; Stuwe et al., 2007; 
Hayashi et al., 2008). In migrating cells such as fibroblasts or 
epithelial cells, NHE1 localizes predominantly to the leading 
edge (Denker et al., 2000; Lagana et al., 2000; Cardone et al., 
2005a; Stock et al., 2007), and findings in fibroblasts indicate 
that NHE1 activity and attachment to the ERM (ezrin/radixin/
moesin) family of plasma membrane F­actin linker proteins are 
required for cell polarity and migration (Denker and Barber, 
2002). This is of substantial interest in the context of human can­
cers, in which metastatic capacity is linked to increased expres­
sion of NHE1 (Cardone et al., 2005b). However, the possible 
link between PDGF signaling and NHE1 in migration/chemo­
taxis has not previously been addressed.
PDGF exists as homo­ or heterodimers of PDGF­A, ­B,   
­C, and ­D chains. Although PDGF­BB activates both homo­ and 
heterodimers of PDGF receptor (PDGFR)  and PDGFR­, 
PDGF­AA is specific for the PDGFR­ homodimer (Heldin 
and Westermark, 1999). Both PDGF­AA and PDGF­BB have 
been shown to stimulate migration in various cell types (Shure 
et al., 1992; Hayashi et al., 1995; Yu et al., 2001). Recently,   
we showed that PDGFR­ signaling is coordinated by the pri­
mary cilium in mammalian fibroblasts (Schneider et al., 2005). 
PDGFR­, which is encoded by a growth arrest–specific (gas) 
gene (Lih et al., 1996), is targeted to the primary cilium, where 
ligand­dependent activation of the receptor and of the ERK1/2 
and protein kinase B/Akt pathways is initiated (Schneider et al., 
2005; unpublished data). The primary cilium is an essential sen­
sory organelle in most growth­arrested mammalian cells and 
coordinates a series of critical signal transduction pathways in 
development  and  tissue  homeostasis,  which,  in  addition  to 
PDGFR­ signaling, include the Hedgehog and Wnt pathways 
(Christensen et al., 2007). In NIH3T3 fibroblasts, we previously 
showed that primary cilia are virtually absent in nonconfluent 
cycling interphase cells but grow on almost all confluent quiescent 
growth­arrested cells within 24 h of serum starvation (Schneider 
et al., 2005). Similarly, serum­starved wild­type (WT) mouse 
embryonic fibroblasts (MEFs) grow normal primary cilia that 
coordinate PDGFR­–mediated signal transduction and direc­
tional cell migration, whereas defects in assembly of the pri­
mary cilium in Tg737
orpk MEFs block these events (Schneider   
et al., 2005; unpublished data). These results indicate that the 
primary cilium is part of the positioning machinery that coordi­
nates cell polarity, which is essential for wound healing and 
developmental processes (Schneider and Haugh, 2006).
In this study, we investigated the interactions between the 
primary cilium and NHE1 in PDGFR­–dependent directional 
cell migration. We demonstrate that NHE1 mRNA and protein 
levels are increased during growth arrest independent of the   
formation of the primary cilium. In contrast, NHE1 activity is 
strongly attenuated by serum deprivation of NIH3T3 fibroblasts, 
which is coincident with the time course of primary cilia appear­
ance (Schneider et al., 2005). NHE1 activity is partly restored by 
stimulation with PDGF­AA, which also stimulates directional 
cell migration (unpublished data). Inhibition of NHE1 activity 
by 5­(N­ethyl­N­isopropyl) amiloride (EIPA) potently inhibits 
PDGF­AA–mediated directional cell migration in growth­ 
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seen in interphase cells (Fig. 2, C and D). This effect was abol­
ished by 5 µM EIPA, demonstrating that stimulation of ciliary 
PDGFR­ partially restored NHE1 activity in growth­arrested 
fibroblasts (Fig. 2, C and D).
Migration of fibroblasts with primary cilia: 
growth-arrested NIH3T3 cells and  
WT MEFs
Having established that NHE1 is up­regulated concomitant with 
formation of the primary cilium and stimulated by ciliary PDGFR­  
signaling, we next addressed the possible functional relation­
ship between ciliary PDGFR­ signaling and NHE1 activity in 
control of directional fibroblast migration. To this end, we per­
formed wound­healing assays and determined two parameters: 
(1) the translocation of the cell during the course of the experiment, 
i.e., the distance covered by the cell over 5 h, and (2) the distance 
covered by the cell specifically in the direction perpendicular to the 
wound, which is a measure of the directionality of movement and 
allows the calculation of the velocity of movement into the wound. 
A summary of the translocation data for NIH3T3 cells and MEFs 
can be found in Table I, and details and original traces are given in 
Figs. 3 and 5 for growth­arrested and interphase NIH3T3 cells and 
in Figs. 4 and 6 for WT and Tg737
orpk MEFs, respectively.
We first determined the effect of EIPA on migration of 
two  types  of  fibroblasts  with  primary  cilia:  growth­arrested 
across the plasma membrane and combines with cytosolic H
+. 
This is followed by a second phase of slow acidification as NH4
+ 
enters the cells (e.g., through K
+ channels) and, finally, a rapid 
acidification when NH3 rushes out as extracellular NH4Cl is re­
moved (Fig. 2). In interphase cells under control conditions, the 
rate of pHi recovery after acidification was 0.24 ± 0.03 pH units/
min (n = 3), and recovery was nearly abolished in the presence 
of 5 µM of the Na
+/H
+ exchanger inhibitor EIPA (Fig. 2, A and D). 
Because we previously established that NHE2, a related Na
+/H
+ 
exchanger isoform that is also partially EIPA sensitive, is not 
detectable in NIH3T3 fibroblasts (Rentsch et al., 2007), this in­
dicates that NHE1 is the major effector in pHi regulation after 
an acid load in these cells.
In growth­arrested NIH3T3 fibroblasts, recovery after acid 
loading was strongly reduced to 15% of that in the presence of 
serum, and under these conditions, inhibition of NHE1 abolished 
the remaining pHi recovery (Fig. 2, B and D). These results dem­
onstrate that in spite of the up­regulation at the mRNA and pro­
tein levels, NHE1 activity is strongly reduced in growth­arrested 
NIH3T3 cells. Consistent with this conclusion, steady­state pHi 
was 7.24 ± 0.09 (n = 3) in interphase cells and 6.82 ± 0.06 (n = 4) 
in growth­arrested cells.
Incubation of growth­arrested NIH3T3 cells with 50 ng/ml 
PDGF­AA for 1 h increased steady­state pHi to 7.10 ± 0.09   
(n = 8) and increased the rate of pHi recovery to 50% of that 
Figure 1.  Expression and localization of NHE1. (A) Quantitative data from real-time PCR analysis (top) and Western blotting (bottom) show up-regulation 
of both mRNA and protein levels of NHE1 during growth arrest in NIH3T3 cells exposed to serum starvation for 0 (interphase cells), 12, and 48 h. The 
up-regulation was reversible, as levels of both mRNA and protein were reduced to interphase levels after the readdition of serum for 24 h. The data shown 
represent 3–11 independent experiments for each condition. Error bars represent the SEM value of the relative C(t) value from each condition (n = 3–5). 
Data were analyzed using parametric or nonparametric ANOVA, and the level of significance is shown (*, P < 0.05). C(t), threshold cycle. (B, a and b) 
Epifluorescence microscopy analysis of primary cilia (red; anti–acetylated -tubulin [tb]; arrows) in growth-arrested WT and Tg737
orpk MEFs (serum starved 
for 48 h). (c and d) Confocal imaging of NHE1 localization (green) in growth-arrested WT (c) and Tg737
orpk (d) MEFs. Arrows indicate lamellipodial 
regions of cells. Note that intracellular NHE1 localization is also seen. (C) Western blot analysis (n = 3) of PDGFR- and NHE1 protein levels in WT and 
Tg737
orpk MEFs after 0, 12, and 48 h of serum starvation. -Actin was used as a loading control. As seen, growth arrest leads to up-regulation of both 
PDGFR- and NHE1 protein levels in both WT and Tg737
orpk MEFs.JCB • VOLUME 185 • NUMBER 1 • 2009   166
in Fig. 3 D. As seen (Fig. 3 D, legend), the cells moved into the 
wound at a velocity of 0.104 ± 0.004 µm/min, whereas in the 
presence of 10 µM EIPA, this velocity was reduced by 75% to 
0.028 ± 0.001 µm/min.
To ascertain that the effect of EIPA on PDGF­AA–stimulated 
migration was not caused by an inhibition of PDGFR­ activa­
tion, we monitored Tyr
754 phosphorylation of PDGFR­, corre­
sponding to receptor activation, after a 5­min exposure to 50 ng/ml 
PDGF­AA in the absence of EIPA and after 1 and 6 h of exposure 
to 5 µM EIPA (Fig. 3 E). As seen, the level of PDGFR­ expres­
sion and the ability of PDGF­AA to induce Tyr
754 phosphoryla­
tion of PDGFR­ were unaffected by the presence of EIPA. 
Furthermore, neither EIPA (Fig. S1 A) nor siRNA­mediated 
knockdown of NHE1 (Fig. S1 B) significantly affected the abil­
ity of fibroblasts to form primary cilia. These results show that the 
inhibitory effect of EIPA on PDGF­AA–induced cell migration is 
not caused by an effect of cilia formation and that EIPA exerts   
its effect on NHE1 downstream from activation of PDGFR­.   
Finally, confirming that the effect of EIPA on cell migration   
reflected inhibition of NHE1, siRNA­mediated knockdown of 
NHE1 inhibited cell migration (Fig. S1 C).
Next, we performed similar experiments on WT MEFs. 
Fig. 4 A shows the trajectories of growth­arrested WT MEFs   
in the presence of PDGF­AA and in the absence and presence   
of EIPA, and Fig. 4 B provides statistical summaries (see also 
NIH3T3 cells and growth­arrested WT MEFs. Fig. 3 A shows 
trajectories of growth­arrested NIH3T3 cells in the absence and 
presence of 50 ng/ml PDGF­AA normalized to common start­
ing points. The radii of the red circles represent the mean dis­
tances covered within the experimental periods of 5 h. Fig. 3 B 
provides a statistical summary of these experiments. In growth­
arrested NIH3T3 cells, translocation was 21 ± 3.6 µm and was 
reduced by 50% by EIPA to 11 ± 1.8 µm. In the presence of 
PDGF­AA, translocation was increased to 45 ± 5.7 µm, and   
under these conditions, translocation was reduced by more than 
two thirds by EIPA to 13 ± 1.5 µm (Fig. 3 B).
Next, we assessed the role of NHE1 specifically in direc­
tional migration of the growth­arrested NIH3T3 cells in the 
presence of PDGF­AA. The directionality of movement was es­
timated by plotting the mean distance covered by the cells in the 
direction perpendicular to the wound edge (Fig. 3 C, the x direc­
tion) as a function of time. The slope of this curve, obtained by 
linear  regression,  corresponds  to  the  velocity  of  directional 
movement into the wound. The slope of the corresponding plots 
for the movement parallel to the wound edge (Fig. 3 C, the y di­
rection) was always close to zero (not depicted), indicating that 
movement in this direction was random and essentially non­
progressing so that directional movement occurred only per­
pendicular to the wound edge. The directional migration data for 
growth­arrested, PDGF­AA–treated NIH3T3 cells are summarized 
Figure 2.  Roles of NHE1 and PDGFR- in pHi 
regulation in NIH3T3 cells during interphase 
and  growth  arrest.  (A–C)  Original  tracings 
of pHi recovery measurements in the absence 
and presence of 5 µM EIPA. 10 mM NH4Cl 
was  present  in  the  Ringer’s  solution  as  indi-
cated by the horizontal line. Cells grown in the 
presence of serum (A), cells which had been 
serum starved for 48 h (B), and serum-starved 
cells treated with 50 ng/ml PDGF-AA for 1 h 
before the experiment (C) are shown. It may 
be noted that the rate of slow acidification in 
the presence of NH4Cl, representing NH4
+ in-
flux via either K
+ channels or other transporters 
with substrate affinity for NH4
+ (Boron, 2004), 
is reduced in the growth-arrested cells in the 
absence but not in the presence of PDGF-AA. 
This indicates that these transporters are regu-
lated during the cell cycle and also means that 
the total acidification after NH4Cl removal is 
less in the growth-arrested cells. However, this 
does not affect the comparison between the 
recovery rates in the absence and presence of 
EIPA. (D) Summary of the pHi recovery rates 
under the conditions shown. The rate of pHi 
recovery (in pH units/minute) was calculated 
from the slope of the initial linear part of the 
curve after NH4Cl removal. Data shown are 
representative traces (A–C) or mean ± SEM of 
three to five experiments per condition. Data 
were analyzed using parametric or nonpara-
metric ANOVA, and the level of significance 
is shown (*, P < 0.05; **, P < 0.01; ***, P < 
0.001). Ctrl., control.167 CILIARY PDGFR- SIGNALING CONTROLS MIGRATION VIA NHE1 • Schneider et al.
stimulation  with  PDGF­AA  did  not  increase  translocation,  and 
NHE1 inhibition similarly reduced translocation after PDGF­AA 
stimulation by 50% (Table I). This indicated that the role of NHE1 
in translocation was reduced in interphase NIH3T3 cells compared 
with growth­arrested, PDGF­AA–treated cells, in which EIPA in­
hibited translocation by 70% (compare with Fig. 3 B and Table I). 
Therefore, we next addressed whether this was also the case for   
directional migration. As seen in Fig. 5 C, in interphase NIH3T3 
cells, migration into the wound proceeded at a velocity of 0.173 ± 
0.002 µm/min under control conditions and was reduced by 55% 
to 0.077 ± 0.001 µm/min in the presence of EIPA compared with 
75% in the growth­arrested cells (compare with Fig. 3 D). In other 
words, inhibition of NHE1 was less efficient in reducing both trans­
location and directional migration in interphase NIH3T3 cells than 
in growth­arrested, PDGF­AA–treated NIH3T3 cells.
To test the hypothesis that this difference reflected the pres­
ence (in growth­arrested NIH3T3 cells) versus absence (in inter­
phase NIH3T3 cells) of a primary cilium, we next performed 
wound­healing assays on the primary cilia–deficient Tg737
orpk 
mutant MEFs (Fig. 6). Tg737
orpk MEFs exhibited a higher trans­
location in the absence of PDGF­AA than did WT MEFs (compare 
Fig. 6 B with Fig. 4 B). This is in accordance with our previous 
findings and indicates that the primary cilium may restrain exces­
sive cell migration (unpublished data).
In another study (unpublished data), we have shown that 
translocation of Tg737
orpk MEFs was unaffected by PDGF­AA 
(Fig. 6 B). Importantly, translocation of Tg737
orpk MEFs was not 
significantly affected by NHE1 inhibition by 10 µM EIPA, nei­
ther in the presence nor in the absence of PDGF­AA (Fig. 6,   
A and B). With respect to directional migration, the velocity 
of migration of Tg737
orpk MEFs into the wound was 0.31 ± 
0.01 µm/min in the absence of EIPA and reduced by only 28% 
to 0.23 ± 0.01 µm/min in the presence of EIPA (Fig. 6 C). 
Compared with the 90% reduction in the WT MEFs (Fig. 4 D), 
Videos 1–3). Exposure to PDGF­AA nearly tripled the trans­
location of WT MEFs from 45 ± 4.2 µm to 111 ± 5.4 µm. Similar 
to what was seen in the growth­arrested NIH3T3 cells, the effect 
of EIPA was substantially greater in the presence of PDGF­AA, 
but in WT MEFs, this effect was even more pronounced than   
in NIH3T3 cells. Inhibition of NHE1 by 10 µM EIPA had no   
statistically significant effect on translocation in WT MEFs in 
the absence of PDGF­AA but nearly abolished translocation in 
the PDGF­AA–treated WT MEFs (Fig. 4 B).
Fig. 4 C shows WT MEFs migrating into the wound and illus­
trates the x and y axes used to estimate directionality, and Fig. 4 D 
summarizes the directionality data. The growth­arrested, PDGF­
AA–treated WT MEFs traveled at a rate of 0.301 ± 0.003 µm/min 
in the direction perpendicular to the wound. Upon inhibition of 
NHE1, this directional migration of WT MEFs was reduced by 
90% to 0.030 ± 0.004 µm/min (Fig. 4 D). Collectively, these data 
indicate that NHE1 activity plays a pivotal role in mediating di­
rectional migration in response to PDGFR­ signaling.
Migration of fibroblasts deficient in 
primary cilia: interphase NIH3T3 cells and 
Tg737
orpk mutant MEFs
To evaluate whether the role of NHE1 in cell migration depends on 
signaling via the primary cilium, we next performed wound­healing 
assays on two types of fibroblasts deficient in primary cilia: inter­
phase NIH3T3 cells, which lack primary cilia, and Tg737
orpk mu­
tant MEFs, which have no or only very short primary cilia and 
exhibit impaired PDGFR­ expression (Schneider et al., 2005) and 
decreased directional migration in response to chemotactic stimuli 
(unpublished data). As seen in Fig. 5 (A and B), the translocation of 
interphase NIH3T3 cells was 60.0 ± 8.7 µm (17 cells in three exper­
iments) under control conditions. Inhibition of NHE1 by 10 µM 
EIPA reduced translocation by 50% to 30.0 ± 3.0 µm (25 cells   
in three experiments). Importantly, in the interphase NIH3T3 cells, 
Table I.  Summary of translocation data
Cell type Primary cilium PDGF-AA EIPA Translocation
µm
NIH3T3 No (interphase)   60 ± 8.7 (17)
NIH3T3 No (interphase)  + 30 ± 3.0 (25)
NIH3T3 No (interphase) +  60 ± 5.4 (26)
NIH3T3 No (interphase) + + 33 ± 2.7 (25)
NIH3T3 Yes   21 ± 3.6 (23)
NIH3T3 Yes  + 11± 1.8 (23)
NIH3T3 Yes +  45 ± 5.7 (25)
NIH3T3 Yes + + 13 ± 1.5 (26)
WT MEF Yes   45 ± 4.2 (53)
WT MEF Yes  + 27 ± 4.4 (22)
WT MEF Yes +  111 ± 5.4 (23)
WT MEF Yes + + 15 ± 1.8 (20)
Tg737
orpk MEF No or very short   75 ± 5.7 (21)
Tg737
orpk MEF No or very short  + 63 ± 5.7 (19)
Tg737
orpk MEF No or very short +  87 ± 7.8 (34)
Tg737
orpk MEF No or very short + + 57 ± 5.7 (30)
The table summarizes the translocation data obtained for NIH3T3 cells, WT MEFs, and Tg737
orpk MEFs in 5-h wound-healing assays as a function of (a) the pres-
ence or absence of a primary cilium, (b) the presence or absence of 50 ng/ml PDGF-AA, and (c) the presence or absence of 10 µM of the NHE1 inhibitor EIPA. The   
absence or presence of primary cilia was assessed by visual inspection and has also been previously described (Schneider et al., 2005). Translocation data are shown 
as mean ± SEM , with the number of cells shown in parenthesis.JCB • VOLUME 185 • NUMBER 1 • 2009   168
Figure 3.  Effects of PDGF-AA and EIPA in wound-healing assays on growth-arrested NIH3T3 fibroblasts. (A) Trajectories (normalized to common starting 
points) of growth-arrested NIH3T3 cells with and without 50 ng/ml PDGF-AA or 10 µM EIPA, as indicated. The radii of the red circles illustrate the mean 
translocation of the cells within a 5-h time period (n = 17–25). (B) Translocation (in micrometers and calculated as the distance between the position of the 
cell center at the beginning and at the end of the experiment) in the absence or presence of PDGF-AA or EIPA as indicated. (A and B) Data are individual 
trajectories (A) or means ± SEM (B) of 23–26 cells in three independent experiments. Data were analyzed using parametric or nonparametric ANOVA, 
and the level of significance is shown (*, P < 0.05; **, P < 0.01; ***, P < 0.001). (C) Images of the left side of the wound in a confluent monolayer of 
growth-arrested NIH3T3 cells (serum starved for 24 h) at time 0 and 4 h after the wound was made. The arrows indicate the x and y directions of move-
ment, which were used for estimating directional migration. (D) Velocity of migration perpendicular to the wound (x direction) in PDGF-AA–stimulated, 
growth-arrested NIH3T3 cells in the absence (open circles) or presence (closed circles) of EIPA. Directionality of movement was estimated by plotting the 
mean of the distance covered by each cell in the x direction as a function of time. The slope of this line is the velocity in x, in micrometers/minute, which 
is taken as a measure of directionality. In PDGF-AA–stimulated, growth-arrested cells, the velocity of movement into the wound is 0.104 ± 0.004 µm/min, 
and in the presence of 10 µM EIPA, this value is reduced to 0.028 ± 0.001 µm/min. Data shown are means ± SEM of 23–26 cells in three independent 
experiments. The velocity in the presence of EIPA is significantly different from that in the absence of EIPA (P < 0.0001). Ctrl., control. (E) NIH3T3 cells 
were serum starved for 24 h to induce growth arrest, exposed to 5 µM EIPA for 0, 1, or 6 h as indicated, and treated with 50 ng/ml PDGF-AA for 5 min 
as indicated (+). Cells were lysed, and Western blots of total and Tyr
754-phosphorylated PDGFR- were performed as described in Materials and methods. 
-Actin was used as a loading control. Data shown are representative of three independent experiments.169 CILIARY PDGFR- SIGNALING CONTROLS MIGRATION VIA NHE1 • Schneider et al.
NHE1 using a more specific approach. To this end, we per­
formed 5­h wound­healing assays similar to those performed on 
NIH3T3 cells and MEFs on growth­arrested NHE1­null PS120 
fibroblasts (PSNEO) and on growth­arrested PS120 fibroblasts 
stably expressing NHE1 (PS120­NHE1; Denker et al., 2000).   
In the growth­arrested state, these cells migrated relatively slowly 
in wound­healing assays. As seen in Fig. 7 A, the mean translo­
cation of the NHE1­expressing cells was 5.8 ± 0.60 µm (n = 52 
cells in six independent experiments) and 8.9 ± 0.71 µm (n = 63 
cells in six independent experiments) in the absence and pres­
ence of PDGF­AA stimulation, respectively (i.e., exposure to 
PDGF­AA–stimulated translocation; P < 0.01). In the NHE1­
null cells, the mean translocation in the 5­h wound­healing   
this demonstrates that the inhibitory effect of EIPA is strongly 
blunted  in  the  cilia­deficient  Tg737
orpk  MEFs.  Collectively, 
these data indicate that NHE1 plays a major role in directional 
migration, in a manner highly dependent on the presence of 
the primary cilium and specifically on ciliary PDGFR­ sig­
naling. NHE1 also plays a role, albeit a lesser role, in the mi­
gration of interphase cells lacking a primary cilium, suggesting 
that several pathways regulate NHE1 during cell migration.
Migration of NHE1-null and hNHE1-
expressing PS120 fibroblasts
Although EIPA is a widely used and relatively specific inhibitor 
of NHE1 activity, we wished to further test the involvement of 
Figure 4.  Effects of PDGF-AA and EIPA in wound-healing assays on growth-arrested WT MEFs. (A) Trajectories (normalized to common starting points) of 
growth-arrested WT MEFs in the presence of 50 ng/ml PDGF-AA and in the absence or presence of 10 µM EIPA, as indicated. The radii of the red circles 
illustrate the mean translocation of the cells within a 5-h time period. (B) Translocation (in micrometers) of growth-arrested WT MEFs in the absence or presence 
of 50 ng/ml PDGF-AA and 10 µM EIPA, as indicated, calculated as described in the legend for Fig. 3. (A and B) Data shown are individual trajectories (A) or 
means ± SEM (B) of 20–53 cells in three to seven independent experiments. Data were analyzed using parametric or nonparametric ANOVA, and the level of 
significance is shown (***, P < 0.001). (C) Images of the left side of the wound in a confluent monolayer of growth-arrested WT MEFs at time 0 and 4 h after 
the wound was made. The arrows indicate the x and y directions of movement, which were used for estimating directional migration. (D) Velocity of migration 
perpendicular to the wound (x direction) in PDGF-AA–stimulated, growth-arrested WT MEFs in the absence (open circles) or presence (closed circles) of EIPA. 
Directionality of movement was estimated by plotting the mean of the distance covered by each cell in the x direction as a function of time. The slope of this line 
yields the velocity in the x direction (in micrometers/minute), which is a measure of directionality. The velocity in growth-arrested, PDGF-AA–treated WT MEFs 
was 0.301 ± 0.003 µm/min in the absence and 0.030 ± 0.004 µm/min in the presence of 10 µM EIPA. Data shown are means ± SEM of 20–53 cells in three 
to seven independent experiments. The velocity in the presence of EIPA is significantly different from that in the absence of EIPA (P < 0.0001). Ctrl., control.JCB • VOLUME 185 • NUMBER 1 • 2009   170
reduced number of primary cilia in the NHE1­null cells (Fig. 7 C). 
Therefore, the extent to which these factors contribute to the 
lack of PDGF­AA–mediated stimulation of migration in NHE1­
null cells requires further investigation. Importantly, this is not 
a concern for the EIPA­treated cells because EIPA affected nei­
ther the ability of cells to form primary cilia (Fig. S1 A) nor the 
activation of PDGFR­ by PDGF­AA (Fig. 3 E).
Discussion
We have previously shown that the primary cilium plays a 
major role in PDGFR­–mediated regulation of cell growth 
assay was 6.6 ± 0.65 µm (n = 45 cells in four independent ex­
periments) and 6.7 ± 0.54 µm (n = 64 cells in four independent 
experiments) in the absence and presence of PDGF­AA stimu­
lation, respectively (i.e., in these cells, there was no effect of   
50 ng/ml PDGF­AA on translocation). Thus, despite the fact that 
growth­arrested PS120 fibroblasts migrate slower than NIH3T3 
cells and WT MEFs, these results confirm our conclusion that 
cells with primary cilia only respond to PDGF­AA stimulation 
when NHE1 can be activated. However, we noted that, com­
pared with NHE1­expressing cells, NHE1­null cells exhibited 
reduced,  although  not  abolished,  PDGFR­  activation  in   
response to PDGF­AA (Fig. 7 B), reflecting a significantly   
Figure 5.  Effect of EIPA in wound-healing assays on interphase NIH3T3 fibroblasts. (A) Trajectories (normalized to common starting points) of interphase 
NIH3T3 cells in the absence or presence of 10 µM EIPA and 50 ng/ml PDGF-AA, as indicated. The radii of the red circles illustrate the mean transloca-
tion of the cells within a 5-h time period. (B) Translocation (shown in micrometers and calculated as the distance between the position of the cell center at 
the beginning and at the end of the experiment) of interphase and growth-arrested NIH3T3 cells with or without EIPA, as indicated. (A and B) Data are 
individual trajectories (A) or means ± SEM (B) of 17–26 cells in three to four independent experiments. Data were analyzed using parametric or nonpara-
metric ANOVA, and the level of significance is shown (*, P < 0.05). (C) Velocity of migration perpendicular to the wound in interphase NIH3T3 cells in 
the absence (open circles) or presence (closed circles) of 10 µM EIPA obtained as described in the legend for Fig. 3. Data shown are means ± SEM of 
17–26 cells in three to four independent experiments. The velocity in the presence of EIPA is significantly different from that in the absence of EIPA   
(P < 0.0001). Ctrl., control.171 CILIARY PDGFR- SIGNALING CONTROLS MIGRATION VIA NHE1 • Schneider et al.
(Besson et al., 1998). This could indicate that the growth arrest–
  induced increase in mRNA and protein levels observed in this study 
reflects increased mRNA stability. However, inhibition of extracel­
lular signal­regulated kinase activity, which is a well­known conse­
quence of serum deprivation in NIH3T3 cells (Schneider et al., 
2005), was reported to stimulate NHE1 promoter activity (Besson 
et al., 1998), which appears to be in accordance with the present 
finding that NHE1 expression is increased during growth arrest. 
The promoter region of NHE1 contains binding sites for sev­
eral transcription factors, which are known or likely known to   
be regulated by serum deprivation, including AP­1 and cAMP   
response element–binding protein (Miller et al., 1991); however, 
the potential roles of these proteins in the up­regulation of NHE1 
observed in this study remain to be tested.
In contrast to the up­regulation of NHE1 expression in 
growth­arrested cells, NHE1 activity in NIH3T3 cells was 
strongly reduced during growth arrest, a finding which is in   
agreement with studies on other cell types (Reshkin et al., 2000;   
Lehoux et al., 2001). Thus, in spite of increased expression, NHE1 
activity was lower in quiescent cells, presumably reflecting a very 
tight control of NHE1 activity under these conditions. Recent 
work has demonstrated a permissive role for an NHE1­mediated 
increase in pHi in cell cycle progression, apparently through regu­
lation of cyclin D expression and Cdc2 kinase activity and, thus, 
control (Schneider et al., 2005), cell migration, and chemo­
sensory responses (unpublished data). In this study, we demon­
strate that the expression but not the activity of the ubiquitous 
Na
+/H
+ exchanger NHE1 is up­regulated upon quiescence in   
serum­free medium, identifying NHE1 as a gas protein. Moreover, 
we show that NHE1 activity is required for control of direc­
tional cell migration by ciliary PDGFR­ signaling, indicating 
that NHE1 activation is a critical event in the physiological re­
sponse to activation of PDGFR­.
The marked, reversible up­regulation of NHE1 protein 
levels upon growth arrest observed in fibroblasts appears to   
occur at the transcriptional level because NHE1 mRNA levels were 
increased to a similar extent. A similar level of up­regulation   
of NHE1 expression upon serum deprivation was previously re­
ported in kidney epithelial cells (Carraro­Lacroix et al., 2006). Up­
regulation of NHE1 expression during growth arrest in Tg737
orpk  
MEFs occurs at a level comparable with that in WT MEFs, indi­
cating that up­regulation proceeds through mechanisms that are 
independent of ciliary assembly. This is in sharp contrast to the 
up­regulation  of  PDGFR­  during  growth  arrest,  which  is 
blocked in Tg737
orpk cells (Schneider et al., 2005). In a previous 
study in NIH3T3 cells stably expressing a fragment of the NHE1 
promoter, it was reported that the addition of serum (from a   
serum level of 0.5 to 10%) increased NHE1 promoter activity 
Figure 6.  Effects of PDGF-AA and EIPA on translocation of 
growth-arrested Tg737
orpk MEFs in wound-healing assays. 
(A)  Trajectories  (normalized  to  common  starting  points) 
of growth-arrested Tg737
orpk MEFs in the presence of 50 
ng/ml PDGF-AA and in the absence or presence of 10 µM 
EIPA, as indicated. The radii of the red circles illustrate the 
mean translocation of the cells within a 5-h time period. (B) 
Translocation (in micrometers) of growth-arrested Tg737
orpk 
MEFs in the absence or presence of 50 ng/ml PDGF-AA 
and 10 µM EIPA, as indicated, calculated as described in 
the legend for Fig. 3. (A and B) Data shown are individual 
trajectories (A) or means ± SEM (B) of 19–34 cells in two 
to four independent experiments. (C) Velocity of migration 
perpendicular to the wound of Tg737
orpk MEFs in the ab-
sence  (open  circles)  or  presence  (closed  circles)  of  EIPA. 
Data shown are means ± SEM of 19–34 cells in two to four 
independent experiments. The velocity in the presence of 
EIPA is significantly different from that in the absence of EIPA 
(P < 0.0001). Ctrl., control.JCB • VOLUME 185 • NUMBER 1 • 2009   172
G2/M entry and transition (Putney and Barber, 2003). It is likely 
that up­regulation of NHE1 expression, but tight repression of its 
activity, serves to prepare the cell such that it can elicit a rapid intra­
cellular alkalinization at the appropriate time for reentry into the 
cell cycle upon delivery of the relevant signal. Thus, the dual con­
trol of NHE1 at the expression and posttranscriptional levels may 
serve as a form of coincidence detection, ensuring that these pro­
cesses are tightly regulated both by cell cycle stage and by the avail­
ability of the relevant ligand. A similar mechanism likely pertains 
to the control of other NHE1­dependent processes (a case in point 
being the directional migration process addressed in this study). 
Finally, although our findings clearly show that the increase in NHE1 
expression was not dependent on the formation of the primary   
cilium, the close temporal correlation between these two impor­
tant consequences of growth arrest warrants future investigations.
Exposure of growth­arrested NIH3T3 cells to the specific 
PDGFR­ ligand PDGF­AA partially restored NHE1 activity, 
which is measured as the global, cytoplasmic NHE1­dependent 
pHi recovery after acidification. Although activation of NHE1 by 
nonisoform­discriminating PDGFR ligands has been demon­
strated in several cell types (Cassel et al., 1983; Ma et al., 1994; 
Yan et al., 2001), this is, to our knowledge, the first study to show 
that a specific PDGFR­ ligand activates NHE1.
Consistent with the marked decrease in NHE1 activity in 
quiescent cells, migration was strongly reduced in growth­arrested 
NIH3T3 cells. In addition to stimulating NHE1 activity, PDGF­AA 
markedly  stimulated  directional  cell  migration  in  growth­ 
arrested NIH3T3 cells in a manner fully dependent on NHE1 
activity. In growth­arrested WT MEFs, which, similar to growth­
arrested NIH3T3 cells, have a primary cilium, both the net trans­
location and the directionality of PDGF­AA–mediated migration 
were similarly dependent on NHE1 activity. In congruence with 
the involvement of NHE1, PDGF­AA had no effect on transloca­
tion in NHE1­null fibroblasts. In the NHE1­null fibroblasts, re­
duced PDGFR­ activation may also have contributed to this 
effect because these cells have problems forming primary cilia as 
compared with their NHE1­expressing counterparts. As neither 
EIPA nor acute siRNA­mediated NHE1 knockdown affected cilia 
formation in NIH3T3 cells, this clearly does not represent a role 
for NHE1 in cilia formation but appears to be an anomaly reflect­
ing long­term genetic alterations in the PSNEO cells, which was 
not further addressed in this study (Putney and Barber, 2004).
In marked contrast, in Tg737
orpk MEFs, which are defi­
cient  in  primary  cilia  and,  thus,  in  PDGFR­  expression   
(Schneider et al., 2005), migration was unaffected by PDGF­AA 
and only very modestly affected by EIPA, further supporting the 
notion of a PDGFR­–NHE1 axis being required for directional 
migration. Because PDGF­AA activates only the homodimeric 
PDGFR­ receptor, which is virtually only localized in the pri­
mary cilium, whereas NHE1 is activated at the leading edge of 
the cell, this poses the question of how activation of NHE1 may 
act at a distance. NHE1 in both WT and Tg737
orpk MEFs local­
ized to the cell surface in the leading edge, which is in agree­
ment with previous studies (Lagana et al., 2000; Denker and 
Barber,  2002;  Stock  et  al.,  2005,  2007;  Frantz  et  al.,  2007; 
Stuwe et al., 2007), but also to intracellular vesicle­like struc­
tures. It remains a possibility that when PDGF­AA is added to 
Figure  7.  Migration, PDGFR- activation, and cilia formation in NHE1-
null and NHE1-expressing cells. (A) PS120 (expressing NHE1) and PSNEO   
(deficient for NHE1) cells were serum starved for 48 h to induce growth arrest, 
and migration was analyzed in 4-h wound-healing assays in the absence 
and presence of 50 ng/ml PDGF-AA, as indicated. The graph shows the 
mean translocation ± SEM of 45–64 cells in four to six independent experi-
ments. Ctrl., control. (B) PS120 and PSNEO (PS120NEO) cells were serum   
starved for 48 h, exposed to 50 ng/ml PDGF-AA, and lysed, and West-
ern blots of total and Tyr
754-phosphorylated PDGFR- were performed as   
described in Materials and methods. -Actin was used as a loading control. 
As seen, PDGFR- expression was similar in the two cell types, whereas 
PDGF-AA–induced phosphorylation of PDGFR- was reduced, although not 
abolished, in the PSNEO cells. Data shown are representative of three inde-
pendent experiments for each cell line. (C) PS120 and PSNEO cells were   
serum starved for 48 h to induce growth arrest, paraformaldehyde fixed, and 
labeled for acetylated -tubulin to visualize primary cilia. Approximately 
300 randomly chosen cells from each experiment were analyzed for the   
presence or absence of primary cilia, and the results shown are the mean ± 
SEM of the percentage of cells with cilia in six independent sets of paired 
experiments. (A and C) Data were analyzed using parametric or nonpara-
metric ANOVA, and the level of significance is shown (*, P < 0.05).173 CILIARY PDGFR- SIGNALING CONTROLS MIGRATION VIA NHE1 • Schneider et al.
and its role in directional migration. These data reinforce the 
possibility that the role of NHE1 in directional migration in re­
sponse to ciliary PDGFR­ signaling involves a local signaling 
circuit at the leading edge of the migrating cells and does not re­
flect the contribution of the transporter to global pHi recovery. 
We can envision a sequences as follows: when PDGF­AA is 
added, (a) important ciliary PDGFR­ signaling components are 
activated, (b) the activation of downstream signaling components 
(e.g., ERK1/2 or Akt) activates NHE1 in the cell membrane for 
ion transport or alternatively promotes increased lamellipodial 
localization of NHE1, and (c) at the leading edge, NHE1, in turn, 
is pivotal for the F­actin organization required for cell migration. 
The effect of NHE1 on F­actin organization may be mediated via 
effects on Cdc42 activity (Frantz et al., 2007), on protein kinase 
activity (Pedersen et al., 2007a), or as a consequence of direct pH 
sensitivity of F­actin regulatory proteins such as cofilin or talin 
(Srivastava et al., 2007). Another possible pathway involves the 
interaction of NHE1 with ERM proteins, which has been found to 
play a role in cell migration (Denker and Barber, 2002) as well   
as in Akt activation after some (Wu et al., 2004) albeit not all 
(Rasmussen et al., 2008) stimuli.
In a few experiments, we observed by immunofluorescence 
microscopy analysis a weak localization of NHE1 to primary 
cilia of NIH3T3 cells (unpublished data), although, in most cases, 
we could not detect increased NHE1 labeling in the cilium. NHE1 
contains two unique ciliary targeting peptide motifs, including an 
N­terminal sequence motif (R14IFP), which is similar to that re­
quired for ciliary targeting of the transient receptor potential ion 
channel, and polycystin­2 (R6VXP; Geng et al., 2006). Although 
speculative at this point, it is thus possible that NHE1 has dual 
functions, i.e., in the primary cilium, where PDGFR­–mediated 
signal transduction is initiated, and in the plasma membrane, 
where NHE1 is activated at the leading edge of migrating cells.
Thus, we have shown in this study that NHE1 activity is 
specifically required for PDGF­AA–mediated stimulation of   
fibroblast migration in a manner downstream from activation of 
PDGFR­ and not reflecting a role for NHE1 in formation of the 
primary cilium. Although a role for leading­edge NHE1 activity 
in cell polarity and directional migration has been demonstrated 
in a variety of cell types (Lagana et al., 2000; Denker and Barber, 
2002; Patel and Barber, 2005; Stock et al., 2005, 2007; Frantz   
et al., 2007; Stuwe et al., 2007), this study is, to our knowledge, 
the first to demonstrate a pivotal role of NHE1 in the response to 
chemical stimuli detected and transmitted through the primary 
cilium. These findings support the notion that the primary cilium 
functions as a cellular positioning detector in directional cell mi­
gration. Therefore, the interplay between the primary cilium and 
NHE1 may be critical to the physiological response to PDGFR­ 
signaling in development processes and tissue homeostasis.
Materials and methods
Cell culture and reagents
Experiments  were  performed  on  NIH3T3  fibroblasts,  WT  and  Tg737
orpk  
mutant MEFs, NHE1-null PS120 fibroblasts (denoted PSNEO), and PS120   
fibroblasts stably expressing NHE1 (provided by D. Barber, University of Cali-
fornia, San Francisco, San Francisco, CA; Denker et al., 2000). Tg737 en-
codes the protein polariz/IFT88, which is part of the intraflagellar transport 
the medium, NHE1 may be transported to the lamellipodial 
plasma membrane at a higher level in quiescent WT cells, pre­
sumably by vesicular exocytosis. However, our initial observa­
tions have not convincingly shown an increase in overall plasma 
membrane localization of NHE1 after PDGF­AA treatment.
Several mechanisms may underlie the linkage between cili­
ary  PDGFR­  signaling  and  NHE1  activation.  One  possible 
pathway is through ERK1/2 and its effector p90RSK, which acti­
vates NHE1 by direct phosphorylation on Ser
703 of its C­terminal 
tail, after several types of stimuli (Takahashi et al., 1999; Cuello 
et al., 2007). Consistent with such a mechanism, we have previ­
ously shown that ERK1/2 is activated in NIH3T3 cells and WT 
MEFs but not in Tg737
orpk MEFs in response to PDGFR­ acti­
vation in the primary cilium (Schneider et al., 2005). The PI3K–
Akt pathway is also activated in MEFs downstream of PDGFR­ 
activation (unpublished data) and could also contribute to NHE1 
stimulation, e.g., by direct phosphorylation of NHE1 (Ser
648 of 
human NHE1 being a high­probability consensus site for phos­
phorylation by Akt1) and/or by inducing actin and microtubule 
cytoskeletal rearrangements.
In contrast to the almost complete ablation of PDGF­AA–
mediated migration by EIPA in cells with primary cilia (i.e., 
growth­arrested NIH3T3 cells and WT MEFs), migration of cells 
lacking cilia (i.e., interphase NIH3T3 cells and Tg737
orpk MEFs) 
had a substantial EIPA­insensitive component. This was also the 
case for unstimulated, growth­arrested cells and points to redun­
dancy and/or compensatory mechanisms in basal cell migration. 
In accordance with this view, translocation in the absence of 
PDGF­AA was similar in growth­arrested NHE1­null and NHE1­
expressing PS120 fibroblasts. In contrast, during interphase 
growth, the rate of cell migration was previously found to be 
40%  lower  in  NHE1­null  compared  with  NHE1­expressing 
PS120 fibroblasts (Denker and Barber, 2002), which is compara­
ble with the difference between growth­arrested and interphase 
NIH3T3 cells seen in this study. The difference between inter­
phase and growth­arrested cells presumably reflects the fact that 
although  NHE1  expression  is  up­regulated  in  growth­arrested 
cells, NHE1 activity is essentially absent (shown in Fig. 2 for 
NIH3T3 cells). Collectively, these data indicate that the relative 
role of NHE1 in directional cell migration is cell cycle state and 
cell type dependent and that other ion transport proteins can fulfill 
roles similar to that of NHE1 under some conditions. A major 
candidate is Na
+­HCO3
 cotransport, for which a role in cell mi­
gration was previously demonstrated (Schwab et al., 2005).
A recent study showed that Na
+­dependent HCO3
 trans­
port appeared more important than NHE1 in pHi regulation in 
both WT and Tg737
orpk choroid plexus epithelia in the mouse 
(Banizs et al., 2007). This only partial role for NHE1 in pHi reg­
ulation contrasts with the fact that during growth arrest when 
primary cilia were present, both NIH3T3 cells and WT MEFs 
were fully dependent on NHE1 activity for PDGF­AA–mediated 
migration. Notably, NHE1 played a greater role in global pHi re­
covery after acidification in interphase NIH3T3 cells than in 
growth­arrested, PDGF­AA–treated NIH3T3 cells (Fig. 2), but 
the relative contribution of NHE1 to both translocation and di­
rectional migration was greater in the latter. In other words, there 
is no strong correlation between the effect of NHE1 on global pHi JCB • VOLUME 185 • NUMBER 1 • 2009   174
and anti-NHE1 (Xb-17; both rabbit antibodies were used at 1:500). Cells 
were washed in PBS and incubated with DAPI (Invitrogen) and Alexa Fluor 
568–conjugated goat anti–mouse IgG and Alexa Fluor 488–conjugated 
goat anti–rabbit IgG (both at 1:1,000; Invitrogen) for 1 h. Preparations 
were mounted in N-propyl-gallate at 2% wt/vol in PBS/glycerin and were 
visualized at room temperature. For standard epifluorescence imaging, cells 
were visualized on a microscope (Eclipse E600; Nikon) with EPI-FL3 filters, 
a 100× 1.25 NA objective, and a cooled charge-coupled device camera 
(MagnaFire; Optronics), For confocal imaging, cells were visualized using a 
40× 1.25 NA Plan-Apochromat objective and the 488-nm Ar/Kr laser line 
of a microscope (DMIRB/E; Leica) with a confocal laser-scanning unit (TSC NT; 
Leica). Optical slice thickness was 1 µm, and pinhole size was 1 airy disc. 
Images shown are frame averaged and presented in RGB pseudocolor. No 
or negligible labeling was detectable in the absence of primary antibody. 
Digital images were processed (overlays and brightness/contrast adjustment 
only) using Photoshop CS2 version 9.0.2 (Adobe).
Measurements of pHi
pHi was monitored at 37°C essentially as previously described (Pedersen   
et al., 2007b). In brief, NIH3T3 cells or WT or Tg737
orpk MEFs were seeded 
on glass coverslips 24–48 h before experiments. Confluency at the time of 
experiments was 80–95%. Cells were loaded with 1.2 µM BCECF-AM in 
Ringer’s solution (150 mM NaCl, 1 mM Na2HPO4, 1 mM CaCl2, 10 mM 
Hepes, and 5 mM glucose, pH 7.4), and mounted in the cuvette of a spec-
trophotometer (Ratiomaster; PTI). Emission was detected at 525 nm after ex-
citation at 445 and 495 nm (NIH3T3 fibroblasts) or 445 and 500 nm 
(MEFs). The 445:495 nm ratio was calculated after background subtraction, 
and calibration to pHi was performed using the 7-point nigericin/high K
+ 
technique, essentially as previously described (Boyarsky et al., 1988). The 
high K
+ Ringer solution was similar to the standard Ringer solution, except 
that 140 mM NaCl was replaced with KCl. The ability of the cells to recover 
after an acid load was evaluated by the NH4Cl prepulse technique: cells 
were exposed to 10 mM NH4Cl in Ringer’s solution for 5 min followed by 
NH4Cl removal to induce intracellular acidification, the recovery from which 
is a measure of the capacity for pHi regulation after an acid load. To estimate 
the contribution of NHE1, experiments were performed in the absence and 
presence of 5 µM EIPA. The effect of PDGF-AA was estimated by preincubat-
ing the cells with 50 ng/ml PDGF-AA for 1 h before the NH4Cl prepulse.   
Because initial pHi was comparable in all experiments for a given cell type, 
pHi recovery was compared by calculating recovery rates (pH units/minute) 
from the slope of the initial linear part of the curve after NH4Cl removal.
Wound-healing assays
Migration of individual NIH3T3 fibroblasts, MEFs, and PS120 fibroblasts 
was assessed with wound-healing assays. Fibroblasts (interphase or quies-
cent as indicated) were grown to 80–90% confluency in 12.5-cm
2 culture 
flasks, and a wound was scratched in the cell layer using a fine sterile pipette 
tip. The culture medium was changed to fresh, serum-free medium, and the 
cells were allowed to recover for 1 h at 37°C/5% CO2 before recording. 
The cells were placed in a heated chamber (37°C) on the stage of an inverted 
microscope (Axiovert 25 or Axiovert 40C; Carl Zeiss, Inc.) equipped with 
10× or 20× objectives. Migration into the wound was monitored for 5 h 
with a video camera (XT-ST70CE and XC-77CE; Hamamatsu Photonics) con-
trolled by HiPic software (Hamamatsu Photonics). In some experiments, cells 
were stimulated with 50 ng/ml PDGF-AA in the absence or presence of   
10 µM EIPA. Images were taken at 15-min intervals and stored as stacks of 
tiff files. For data analysis, the circumferences of the cells were labeled at 
each time step throughout the entire image stacks using Amira software 
(Mercury Computer Systems; http://www.tgs.com/) as described previously 
(Dreval et al., 2005; Dieterich et al., 2008). Migration was quantified as the 
movement of the cell center. The x and y coordinates of the cell center (in 
micrometers) were determined as geometric means of equally weighted 
pixel positions within the cell outlines. We used two parameters to quantify 
migration. The translocation (in micrometers) was calculated as the mean dis-
tance between the position of the cell center at the beginning and at the end 
of the experiment for the observed group of cells. Translocation summarizes 
stochastic movements of the cells (Dreval et al., 2005; Dieterich et al., 2008) 
and contributions from directed migration induced by the wound-healing   
condition and is a measure of sustained migration (Schwab et al., 2006). 
The directionality of movement was estimated by plotting the mean of the nu-
merical distance of the cells traveled in the direction perpendicular to the 
wound (the x direction) as a function of time. The mean positions of cells 
were fitted to the functions x(t) = vx × t and y(t) = vy × t. The velocities vx and vy  
and their uncertainties were estimated with the least-square fit routine of   
gnuplot (http://www.gnuplot.info/). The slope of the x distance versus time 
protein complex responsible for assembly and maintenance of the primary 
cilium (Rosenbaum and Witman, 2002), and Tg737
orpk MEFs form no or only 
very short primary cilia (Schneider et al., 2005). PS120 fibroblasts are Chi-
nese hamster lung fibroblasts deficient in NHE1 and were transfected either 
with rat NHE1 or control vector (Denker et al., 2000). NIH3T3 cells were 
grown in DME (Invitrogen) with 10% fetal calf serum (Invitrogen) and 1%   
penicillin-streptomycin (Invitrogen). MEFs were grown in 50% DME and 50% 
F12 Ham (Invitrogen) with 10% fetal calf serum and 1% penicillin-streptomycin. 
PS120 cells were grown in DME with 5% fetal calf serum, 1% penicillin- 
streptomycin, and 400 µg/ml G418. All cells were maintained at 37°C, 5% 
CO2, and 95% humidity. Cells were examined at either 70% confluency   
in the presence of serum (interphase cells) or at 90% confluency followed by 
serum starvation for 12 or 48 h to induce growth arrest, or serum was read-
ded to the 48-h serum-starved cells for 24 h to stimulate cell cycle entrance. 
PDGF-AA was purchased from R&D systems, and stock solutions were pre-
pared at 50 µg/µl in 4 mM HCl/0.1% BSA. EIPA was purchased from Invit-
rogen and was prepared as a 5-mM stock in double-distilled H2O, and 
BCECF-AM  (2,7-bis-[2-carboxyethyl]-5,6-carboxyfluorescein,  tetraacetoxy-
methylester), which was also purchased from Invitrogen, was prepared as a 
1.6-mM stock in desiccated DMSO.
Real-time PCR
Cells were grown in Petri dishes and washed with ice-cold PBS, and RNA 
was purified using the RNeasy Mini kit (QIAGEN). RNA was converted to 
cDNA by reverse transcription using Superscript RT II (Invitrogen) and 250 
µg/µl random primers (Invitrogen) according to the manufacturer’s instruc-
tions. Real-time PCR set up was performed as triplets of each individual 
sample using 1 µg cDNA and 19 µl master mix (2 µM forward primer   
5-CGAACTGCTACACATCCTTGTCTT-3, 2 µM reverse primer 5-GTCATA-
GCTGGCAAATTCCTC-3, 2 µM NHE1 TaqMan probe 5-TGCCGTCACT-
GTGGTCCTCTATCACCT-3, 30 nM reference dye [Agilent Technologies 
Inc.], and Brilliant QPCR master mix [Agilent Technologies Inc.]). 18S was 
used as a reference gene (18S master mix: 2 µM forward primer 5-TTTAATA-
TACGCTATTGGAGCTGGAA-3, 2 µM reverse primer 5-GGATCCATTGG-
AGGGCAAGT-3,  2  µM  NHE1  TaqMan  probe  5-TACCGCGGCTGC-
TGGCACC-3, 30 nM reference dye, and Brilliant QPCR master mix). 
Quantitative PCR was performed using a real-time thermal cycler (Agilent   
Technologies, Inc.; 95°C for 10 min, 40 cycles of 95°C for 30 s, and 58°C 
for 1 min), and data were analyzed with Mx4000 software (Agilent Technolo-
gies, Inc.).
SDS-PAGE and Western blot analysis
Cells grown in Petri dishes were washed in ice-cold PBS, lysed in 100 µl 
boiling lysis buffer with 0.1% SDS, scraped off, and transferred 10–15 
times through a 27-gauge needle. Lysates were centrifuged at 16,000 g 
to precipitate debris, and protein concentrations were estimated using 
a BCA kit (Thermo Fisher Scientific). Proteins were analyzed by SDS-
PAGE  and  Western  blot  analysis  using  the  XCell  and  XCell  II  blot   
module systems (Novex) as previously described (Christensen et al., 
2001). In brief, proteins were separated by gel electrophoresis under 
denaturing and reducing conditions on 10% NuPAGE Bis-Tris gels using 
NuPAGE MOPS SDS running buffer (NP0002) and Fermentas protein 
standards. Separated proteins were electrophoretically transferred to 
nitrocellulose membranes, which were stained in 1% Ponceau S red so-
lution, and incubated for 2 h at room temperature in blocking buffer 
(5% nonfat dry milk in TBST [0.01 M Tris-HCl, 0.15 M NaCl, 0.1% 
Tween 20, pH 7.4]) before incubation with primary antibodies in block-
ing buffer overnight at 4°C. The antibodies used were rabbit polyclonal 
anti–PDGFR-  (1:600;  Santa  Cruz  Biotechnology,  Inc.),  rabbit  poly-
clonal  anti–phospho-Tyr
754–PDGFR-  (1:200;  Santa  Cruz  Biotechno-
logy, Inc.), anti-NHE1 (1:500; Xb-17 rabbit polyclonal was a gift of   
M. Musch, University of Chicago, Chicago, IL), and mouse monoclonal 
anti–-actin (1:10,000; Sigma-Aldrich). Labeling was detected by incu-
bation with alkaline phosphatase-coupled secondary antibodies (1:200) 
in blocking buffer for 1 h followed by development using 5-bromo-4-
chloro-3-indolyl  phosphate/nitro  blue  tetrazolium  (Kirkegaard  and 
Perry Laboratories, Gaithersburg, MD).
Immunofluorescence analysis
Cells were grown on glass coverslips in 6-well test plates (Cellstar) and 
fixed in 4% paraformaldehyde for 15 min at room temperature followed 
by permeabilization in 0.2% Triton X-100. Cells were quenched in PBS with 
2% BSA for 30 min and incubated with the following primary antibodies 
at  room  temperature  for  2  h:  anti–acetylated  -tubulin  (1:5,000  mouse 
antibody; Sigma-Aldrich), anti–PDGFR- (Santa Cruz Biotechnology, Inc.), 175 CILIARY PDGFR- SIGNALING CONTROLS MIGRATION VIA NHE1 • Schneider et al.
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plot is the velocity in the x direction (in micrometers/minute) and is a mea-
sure of directionality in our experimental setup. The corresponding plots for 
directionality in the y direction (parallel to the wound) were always close to 
zero, indicating that in this experimental setup, directional movement is mea-
sured only perpendicular to the wound.
siRNA-mediated knockdown of NHE1
NHE1  knockdown  in  NIH3T3  cells  was  performed  using  SMARTpool 
siRNA (Thermo Fisher Scientific) against mouse NHE1 (NHE1) or scram-
bled oligonucleotides of comparable GC content (mock), both at 50 nM, 
and FECT transfection agent (Thermo Fisher Scientific) according to the 
manufacturer’s instructions. The day after siRNA treatment, the cells were 
serum starved as described in Cell culture and reagents and were used for 
experiments 48 or 72 h after siRNA treatment as indicated. Cilia counting 
experiments were always accompanied by parallel Western blots against 
NHE1 to verify knockdown.
Statistics
All experiments were repeated 3–11 times, and data are presented as rep-
resentative individual experiments or as mean values ± SEM. The data 
were tested for significance using analysis of variance (ANOVA) or Kruskal 
Wallis test (nonparametric ANOVA). The level of significance was set at   
P < 0.05 except where otherwise stated.
Online supplemental material
Fig. S1 shows the effects of EIPA and NHE1 knockdown in NIH3T3 fibroblasts. 
Video 1 shows the migration of growth-arrested WT MEFs in a wound-healing 
assay in the absence of EIPA and PDGF-AA. Videos 2 and 3 show the migration 
of PDGF-AA–stimulated, growth-arrested WT MEFs in a wound-healing assay 
in the absence or presence of EIPA, respectively. Online supplemental material 
is available at http://www.jcb.org/cgi/content/full/jcb.200806019/DC1.
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